TrialCancer immunology, immunotherapy : CII2017

Combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma-safety and efficacy in a phase II study.

Benjamin Weide et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.